A. Kassim

发表

Sickle cell disease, vasculopathy, and therapeutics.

M. DeBaun, A. Kassim, 2013, Annual review of medicine.

Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial)

K. Neville, S. Phillips, F. Kirkham, 2016, American journal of hematology.

End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.

M. Gladwin, J. Makani, D. E. Bauer, 2019, Blood advances.

The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease

M. DeBaun, A. Kassim, 2014, Expert opinion on pharmacotherapy.

How I Treat How I treat and manage strokes in sickle cell disease

M. DeBaun, A. Kassim, S. Pruthi, 2015 .

How I treat and manage strokes in sickle cell disease.

M. DeBaun, A. Kassim, S. Pruthi, 2015, Blood.

Non-invasive imaging of oxygen extraction fraction in adults with sickle cell anaemia.

A. O. Scott, Meher R. Juttukonda, Melissa C. Gindville, 2016, Brain : a journal of neurology.

Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation.

Heidi Chen, A. Kassim, B. Savani, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CFD models of cerebrovascular wall shear stress in patients with sickle cell disease

J. Gore, J. Gatenby, M. DeBaun, 2013 .

Association between hospital admissions and healthcare provider communication for individuals with sickle cell disease

M. DeBaun, R. Cronin, A. Kassim, 2020, Hematology.

Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study

M. DeBaun, R. Cronin, A. Kassim, 2018, Hematology.

Modifying factors of the health belief model associated with missed clinic appointments among individuals with sickle cell disease

M. DeBaun, R. Cronin, A. Kassim, 2018, Hematology.

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: Prognostic features and outcomes

A. Kassim, S. Brandt, D. Morgan, 2007, Leukemia & lymphoma.

Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape.

A. Kassim, Deva Sharma, 2017, Hematology/oncology and stem cell therapy.

Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post‐transplant cytoxan for sickle cell disease

Heidi Chen, A. Kassim, J. de la Fuente, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa

M. DeBaun, A. Kassim, H. Bello-Manga, 2016, Expert review of hematology.

Elevated tricuspid regurgitant jet velocity, reduced forced expiratory volume in 1 second, and mortality in adults with sickle cell disease

M. DeBaun, A. Kassim, Shruti Chaturvedi, 2017, American journal of hematology.

Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria

A. Kassim, J. Greer, B. Savani, 2012, Bone Marrow Transplantation.

Adapting medical guidelines to be patient-centered using a patient-driven process for individuals with sickle cell disease and their caregivers

Tilicia L. Mayo-Gamble, M. DeBaun, R. Cronin, 2018, BMC Hematology.

Barriers and facilitators to research participation among adults, and parents of children with sickle cell disease: A trans‐regional survey

M. DeBaun, R. Cronin, A. Kassim, 2016, American journal of hematology.

Safety of 3 Tesla Magnetic Resonance Imaging in Patients with Sickle Cell Disease

M. Donahue, L. Jordan, A. Kassim, 2021, Radiology research and practice.

Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia.

Melissa C. Gindville, M. DeBaun, L. Jordan, 2014, Blood.

Increased Patient Activation Is Associated with Fewer Emergency Room Visits and Hospitalizations for Pain in Adults with Sickle Cell Disease.

Tim Lucas Dorner, M. DeBaun, R. Cronin, 2018, Pain medicine.

Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.

A. Kassim, J. Greer, B. Savani, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: ‘what is the best recipe?’

S. Mineishi, A. Kassim, J. Ferrara, 2005, Bone Marrow Transplantation.

Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen.

A. Kassim, S. Brandt, O. Oluwole, 2012, Experimental hematology.

Cognitive deficits are associated with unemployment in adults with sickle cell anemia

M. DeBaun, L. Jordan, A. Kassim, 2016, Journal of clinical and experimental neuropsychology.

Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma

S. Phillips, A. Kassim, R. Cornell, 2018, Bone Marrow Transplantation.

Transfusion support in patients with sickle cell disease.

A. Kassim, J. Andrews, A. Ogbenna, 2020, Seminars in hematology.

Reduction in seroprevalence of viral transfusion‐transmitted infections in southwest Nigeria in children with sickle cell disease using an enhanced screening strategy

A. Kassim, J. Andrews, A. Ogbenna, 2022, British journal of haematology.

Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation.

R. Jayani, A. Kassim, C. Kitko, 2022, Transplantation and cellular therapy.

Capacity Building for Primary Stroke Prevention Teams in Children Living With Sickle Cell Anemia in Africa.

K. Neville, F. Kirkham, M. DeBaun, 2021, Pediatric neurology.

Using novel magnetic resonance imaging methods to predict stroke risk in individuals with sickle cell anemia.

M. Donahue, L. Jordan, A. Kassim, 2020, Hematology/Oncology and Stem Cell Therapy.

Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low‐resource setting: evidence from the SPRING trial

M. DeBaun, L. Jordan, A. Kassim, 2020, British journal of haematology.

Intracranial and Extracranial Vascular Stenosis as Risk Factors for Stroke in Sickle Cell Disease.

M. Donahue, M. DeBaun, L. Jordan, 2020, Pediatric neurology.

Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative.

M. DeBaun, T. Koyama, A. Kassim, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Silent infarct is a risk factor for infarct recurrence in adults with sickle cell anemia

Meher R. Juttukonda, M. Donahue, M. DeBaun, 2018, Neurology.

Alternative donor allogeneic hematopoietic cell transplantation for hemoglobinopathies.

M. Aljurf, A. Kassim, C. Fitzhugh, 2016, Seminars in hematology.

Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): Challenges of conducting a feasibility trial

K. Neville, S. Phillips, F. Kirkham, 2015, Pediatric blood & cancer.

T-cell deplete versus T-cell replete haploidentical hematopoietic stem cell transplantation for sickle cell disease: where are we?

A. Kassim, J. Connelly, A. Akinsete, 2019, Expert review of hematology.

History of parvovirus B19 infection is associated with silent cerebral infarcts

M. DeBaun, A. Kassim, M. Rodeghier, 2018, Pediatric blood & cancer.

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide

Heidi Chen, A. Kassim, M. Jagasia, 2020, EJHaem.

The double-edged sword of AlloHCT for SCD.

A. Kassim, 2020, Blood.

Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.

J. Crowe, M. Rock, S. Yoder, 2012, Experimental hematology.

Regulatory T cell expression of CLA or α4β7 and skin or gut acute GVHD outcomes

J. Crowe, M. Rock, S. Yoder, 2011, Bone Marrow Transplantation.

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.

C. Hofmeister, A. Krishnan, S. Singhal, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Phase 2 trial of montelukast for prevention of pain in sickle cell disease.

M. DeBaun, P. Simpson, A. Kassim, 2020, Blood advances.

Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma.

J. Moslehi, B. Ky, A. Kassim, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Haploidentical bone marrow transplantation improves cerebral hemodynamics in adults with sickle cell disease

Meher R. Juttukonda, M. Donahue, M. DeBaun, 2019, American journal of hematology.

Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT

A. Kassim, B. Savani, M. Jagasia, 2011, Bone Marrow Transplantation.

Haploidentical Allogeneic Stem Cell Transplantation in Sickle Cell Disease: a Systematic Review and Meta-analysis.

M. Leeflang, B. Biemond, A. Kassim, 2021, Transplantation and cellular therapy.

New allergies after cord blood transplantation.

A. Kassim, H. Frangoul, J. Greer, 2013, Cytotherapy.

Low FEV1 is associated with fetal death in pregnant women with sickle cell disease

M. DeBaun, A. Kassim, M. Rodeghier, 2020, American journal of hematology.

Systemic Light Chain Amyloidosis - Panel Members

A. Krishnan, S. Singhal, C. Huff, 2014 .

Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study

S. Mineishi, A. Kassim, D. Morgan, 2005, Bone Marrow Transplantation.

The use of venetoclax‐based salvage therapy for post‐hematopoietic cell transplantation relapse of acute myeloid leukemia

R. Jayani, A. Kassim, B. Savani, 2020, American journal of hematology.

Allogeneic hematopoietic stem cell transplant (HSCT) in adults with acute myeloid leukemia (AML) – a single program experience

R. Obenchain, A. Kassim, S. Brandt, 2006 .

Thyroid abnormalities in patients treated with lenalidomide for hematological malignancies: Results of a retrospective case review

A. Kassim, M. Figaro, S. Jagasia, 2011, American journal of hematology.

Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience

G. Mufti, D. Mclornan, A. Kassim, 2019, Front. Oncol..

Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update

A. Kassim, J. de la Fuente, A. Akinsete, 2020, Hematology/Oncology and Stem Cell Therapy.

103: Poor outcome of autologous-bone marrow transplant (auto-BMT) following failed peripheral blood stem cell (PBSC) mobilization

Heidi Chen, A. Kassim, D. Morgan, 2007 .

PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL ANEMIA LIVING IN AFRICA: THE FALSE CHOICE BETWEEN PATIENT-ORIENTED RESEARCH AND HUMANITARIAN SERVICE.

S. Phillips, M. DeBaun, L. Jordan, 2016, Transactions of the American Clinical and Climatological Association.

Decreased median survival of adults with sickle cell disease after adjusting for left truncation bias: a pooled analysis.

M. DeBaun, K. Ataga, A. Kassim, 2019, Blood.

Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.

M. Robin, N. Russell, H. Greinix, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

303: Incidence and outcome of chronic graft-versus-host disease (cGVHD) after allogeneic stem cell transplant (SCT) using National Institute of Health (NIH) consensus criteria

Heidi Chen, A. Kassim, H. Frangoul, 2007 .

Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy

A. Kassim, Alexis Leonard, 2022, Journal of clinical medicine.

Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility

A. Kassim, S. Hashmi, H. Aslam, 2018, Bone Marrow Transplantation.

Targeted Busulfan therapy with a steady-state concentration of 600–700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant

A. Kassim, H. Frangoul, R. Ho, 2014, Bone Marrow Transplantation.

Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies.

D. Crawford, K. Brown-Gentry, Heidi Chen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

World Health Organization’s Growth Reference Overestimates the Prevalence of Severe Malnutrition in Children with Sickle Cell Anemia in Africa

M. DeBaun, A. Kassim, M. Aliyu, 2020, Journal of clinical medicine.

SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies

A. Kassim, J. Chappell, N. Halasa, 2022, Blood Reviews.

Hematopoietic stem cell transplantation for acute myeloid leukemia: A review.

A. Kassim, B. N. Savani, 2017, Hematology/oncology and stem cell therapy.

Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.

C. Hofmeister, S. Singhal, Rashmi Kumar, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone

A. Erath, A. Kassim, J. Patanella, 2020, World journal of oncology.

Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?

P. Pohlmann, A. Kassim, J. Greer, 2009, Blood.

Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.

Heidi Chen, A. Kassim, B. Savani, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient.

A. Kassim, G. Boivin, Yi-Wei Tang, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Minimal residual disease in myeloma: are we there yet?

Annette S. Kim, A. Kassim, C. Mosse, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients.

C. Fonnesbeck, A. Kassim, N. Halasa, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low rates of anti-recipient isohemagglutinins in ABO incompatible hematopoietic stem cell transplants.

Q. Eichbaum, A. Kassim, J. Andrews, 2020, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Factors associated with growth and blood pressure patterns in children with sickle cell anemia: Silent Cerebral Infarct Multi‐Center Clinical Trial cohort

M. DeBaun, A. Kassim, B. Saville, 2015, American journal of hematology.

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.

M. Bar, J. Wagner, J. Sierra, 2021, Transplantation and cellular therapy.

Multiple myeloma

S. Singhal, C. Huff, G. Tricot, 2001, Bone Marrow Transplantation.

Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial.

K. Neville, F. Kirkham, M. DeBaun, 2022, The Lancet. Haematology.

Systematic Review/Meta-Analysis on Efficacy of Allogeneic Hematopoietic Cell Transplantation in Sickle Cell Disease: An International Effort on Behalf of the Pediatric Diseases Working Party of European Society for Blood and Marrow Transplantation and the Sickle Cell Transplantation International Co

M. Aljurf, A. El-Jawahri, A. Kassim, 2021, Transplantation and cellular therapy.

Moderate fixed‐dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial

K. Neville, F. Kirkham, M. DeBaun, 2020, American journal of hematology.

Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers

C. Vnencak-Jones, A. Kassim, J. Greer, 2012, Bone Marrow Transplantation.

Risk Factors for 30-Day Readmission in Adults with Sickle Cell Disease.

M. DeBaun, A. Kassim, B. Covert, 2017, The American journal of medicine.

Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology.

C. Hofmeister, A. Krishnan, S. Singhal, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

Medhat Askar, Effie W Petersdorf, Kwang Woo Ahn, 2014, Blood.

Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation

J. Crowe, M. Rock, S. Yoder, 2016, Haematologica.

Updates to the NCCN Guidelines

A. Krishnan, S. Singhal, C. Huff, 2013 .

Haploidentical Bone Marrow Transplant with Post-Transplant Cytoxan Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Multicenter Learning Collaborative

M. DeBaun, T. Koyama, A. Kassim, 2016 .

Low forced expiratory volume is associated with earlier death in sickle cell anemia.

M. DeBaun, R. Strunk, A. Kassim, 2014, Blood.

Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric

T. Koyama, A. Kassim, B. Savani, 2017, Cornea.

Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study

A. Kassim, B. Savani, M. Jagasia, 2020, Annals of Hematology.

Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).

Heidi Chen, A. Kassim, J. Greer, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure

N. Russell, H. Greinix, A. Kassim, 2014, Haematologica.

Characterizing Intracranial Hemodynamics in Sickle Cell Anemia: Impact of Patient-Specific Viscosity

J. Gore, J. Gatenby, A. Kassim, 2021, Cardiovascular Engineering and Technology.

Salvage second hematopoietic cell transplantation in myeloma.

J. Vose, A. Krishnan, S. Lonial, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation.

A. Kassim, H. Frangoul, J. Greer, 2011, Cytotherapy.

Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count.

Heidi Chen, A. Kassim, J. Greer, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.

A. Krishnan, S. Singhal, Rashmi Kumar, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.

C. Hofmeister, S. Singhal, Rashmi Kumar, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.

C. Hofmeister, S. Singhal, Rashmi Kumar, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience

R. Jayani, A. Kassim, O. Oluwole, 2022, British journal of haematology.

J. Warner, Heidi Chen, A. Kassim, 2021, Journal of hematology.

Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.

Heidi Chen, A. Kassim, H. Frangoul, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Multiple myeloma, version 1.2013.

A. Krishnan, S. Singhal, Rashmi Kumar, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD.

D. Crawford, K. Brown-Gentry, Heidi Chen, 2011, Blood.

Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity

A. Kassim, R. Cornell, 2016, Bone Marrow Transplantation.

Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies.

A. Kassim, S. Brandt, D. Morgan, 2012, Experimental hematology.

Characterizing Intracranial Hemodynamics in Sickle Cell Anemia: Impact of Patient-Specific Viscosity

J. Gore, J. Gatenby, A. Kassim, 2021, Cardiovascular Engineering and Technology.

Results from AMBER, a randomized phase 2 study of bevacizumab and bortezomib versus bortezomib in relapsed or refractory multiple myeloma

J. Yi, V. Paton, A. Kassim, 2013, Cancer.

Relapsed or refractory large B‐cell lymphoma after chimeric antigen receptor T‐cell therapy: Current challenges and therapeutic options

R. Jayani, A. Kassim, O. Oluwole, 2023, British journal of haematology.

Efficacy and Pharmacoeconomic Impact of Letermovir for CMV Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients

A. Kassim, B. Savani, M. Jagasia, 2019, Biology of Blood and Marrow Transplantation.

Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.

D. K. Jung, A. Kassim, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma

A. Kassim, C. Mosse, R. Cornell, 2020, Bone Marrow Transplantation.

Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.

A. Krishnan, R. Vij, P. Hari, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clustering of end‐organ disease and earlier mortality in adults with sickle cell disease: A retrospective‐prospective cohort study

M. DeBaun, A. Kassim, Shruti Chaturvedi, 2018, American journal of hematology.

Allogeneic Stem Cell Transplantation for FLT3/ITD Positive Acute Myeloid Leukemia in CR1: Implication for Personalized Therapy to Prevent Early Relapses

A. Kassim, J. Greer, M. Jagasia, 2012 .

Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis.

S. Phillips, A. Kassim, A. Langone, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

TP53 mutations are associated with increased infections and reduced hematopoietic cell transplantation rates in myelodysplastic syndrome and acute myeloid leukemia.

R. Jayani, A. Kassim, S. Strickland, 2022, Transplantation and cellular therapy.

NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022.

J. Bolaños-Meade, Y. Nieto, A. El-Jawahri, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy.

Heidi Chen, A. Kassim, B. Savani, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Post-allograft pomalidomide and reversible hepatotoxicity

A. Kassim, M. Jagasia, J. Pauff, 2014, Bone Marrow Transplantation.

Post-Transplant Therapy Is More Important Than Induction Regimen Choice in Autologous Hematopoietic Cell Transplantation (AHCT) Recipients for Multiple Myeloma (MM)

A. Krishnan, P. Hari, Y. Nieto, 2015 .

Nocturnal enuresis in sickle cell disease

M. DeBaun, A. Kassim, Rachel B Wolf, 2014, Expert review of hematology.

Is There Still a Role for Macrolide Therapy

Sarfraz A. Saleemi, A. Kassim, B. Savani, 2015 .

Rapidly progressive acute chest syndrome in individuals with sickle cell anemia: a distinct acute chest syndrome phenotype

M. DeBaun, A. Kassim, Shruti Chaturvedi, 2016, American journal of hematology.

Implementing a standard-of-care clinic for stroke prevention in children with sickle cell disease in Nigeria: a feasible strategy outside a clinical trial setting

K. Neville, S. Phillips, F. Kirkham, 2017 .

A case series describing causes of death in pregnant women with sickle cell disease in a low‐resource setting

M. DeBaun, A. Kassim, A. James, 2018, American journal of hematology.

Third trimester and early postpartum period of pregnancy have the greatest risk for ACS in women with SCD

M. DeBaun, A. Kassim, A. James, 2019, American journal of hematology.

Six Month Freedom from Treatment Failure is an Important Endpoint for Acute Graft-Versus-Host Disease Clinical Trials

Heidi Chen, A. Kassim, J. Greer, 2013, Bone Marrow Transplantation.

Multidisciplinary care results in similar maternal and perinatal mortality rates for women with and without SCD in a low‐resource setting

M. DeBaun, A. Kassim, A. James, 2018, American journal of hematology.

Vaccinations Efficacy in Long Term Survivors After Allogeneic Stem Cell Transplantation: Implication of Repeat Vaccinations and Documenting Vaccination Efficacy.

A. Kassim, J. Greer, B. Savani, 2009 .

Acute Vaso-Occlusive Pain is Temporally Associated with the Onset of Menstruation in Women with Sickle Cell Disease.

M. DeBaun, M. Wellons, S. Bruehl, 2019, Journal of women's health.

Implementation of multidisciplinary care reduces maternal mortality in women with sickle cell disease living in low‐resource setting

M. DeBaun, A. Kassim, A. James, 2017, American journal of hematology.

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia

A. Kassim, J. Greer, B. Savani, 2018, Bone Marrow Transplantation.

Sustainability of low maternal mortality in pregnant women with SCD in a low-resource setting

M. DeBaun, A. Kassim, M. Rodeghier, 2022, Blood advances.

Multi-Disciplinary Obstetrics and Sickle Cell Disease Clinic in Low Resource Setting Lowers Maternal and Perinatal Death Rates to the Same Levels As Those without Sickle Cell Disease

M. DeBaun, A. Kassim, A. James, 2017 .

Evaluation of healthcare-associated infection rates in patients with hematologic malignancies and stem cell transplantation during the coronavirus disease 2019 (COVID-19) pandemic

A. Kassim, Laura J. Bobbitt, Katie S. Gatwood, 2022, Antimicrobial Stewardship & Healthcare Epidemiology.

Reduced oxygen extraction efficiency in sickle cell anemia patients with evidence of cerebral capillary shunting

Meher R. Juttukonda, M. Donahue, L. Jordan, 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Differential cerebral hemometabolic responses to blood transfusions in adults and children with sickle cell anemia

Meher R. Juttukonda, Melissa C. Gindville, M. Donahue, 2018, Journal of magnetic resonance imaging : JMRI.

Preliminary evidence for cerebral capillary shunting in adults with sickle cell anemia

Meher R. Juttukonda, Melissa C. Gindville, M. Donahue, 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy

Heidi Chen, A. Kassim, C. Mosse, 2018, Bone Marrow Transplantation.

Low- Versus Moderate-Dose Hydroxyurea for Secondary Stroke Prevention in Children with Sickle Cell Disease in Sub-Saharan Africa: Final Results of a Randomized Controlled Trial, Sprint Trial

M. DeBaun, L. Jordan, A. Kassim, 2020 .

Silent infarction in sickle cell disease is associated with brain volume loss in excess of infarct volume

M. Donahue, M. DeBaun, A. Kassim, 2023, Frontiers in Neurology.

Cerebral Hemodynamics and Executive Function in Sickle Cell Anemia

Rachel E. Siciliano, M. Donahue, M. DeBaun, 2021, Stroke.

Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial

K. Neville, F. Kirkham, M. DeBaun, 2020, Pediatric hematology and oncology.

Technology use and preferences to support clinical practice guideline awareness and adherence in individuals with sickle cell disease

Laurie L. Novak, Gretchen Purcell Jackson, Robert M. Cronin, 2018, J. Am. Medical Informatics Assoc..

Erratum to: Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial) (American Journal of Hematology, (2017), 92, 8, (780-788), 10.1002/ajh.24770)

K. Neville, S. Phillips, F. Kirkham, 2018 .

Pregnancy outcomes in women with sickle‐cell disease in low and high income countries: a systematic review and meta‐analysis

M. DeBaun, A. Kassim, M. Aliyu, 2016, BJOG : an international journal of obstetrics and gynaecology.

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC2)

Michael J. Eckrich, M. DeBaun, T. Koyama, 2020, Blood.

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.

C. Hofmeister, S. Singhal, Rashmi Kumar, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.

A. Krishnan, S. Singhal, Rashmi Kumar, 2012, The Journal of the National Comprehensive Cancer Network.

Contraceptive Methods and the Impact of Menstruation on Daily Functioning in Women with Sickle Cell Disease

M. DeBaun, A. Kassim, A. James, 2019, Southern medical journal.

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.

C. Hofmeister, A. Krishnan, S. Singhal, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

W. Wood, A. Gratwohl, M. Aljurf, 2014, Blood.

Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.

J. Crowe, M. Rock, S. Yoder, 2012, Experimental hematology.

TP53 mutations are associated with increased infections and reduced hematopoietic cell transplantation rates in myelodysplastic syndrome and acute myeloid leukemia.

R. Jayani, A. Kassim, S. Strickland, 2023, Transplantation and cellular therapy.

Acute priapism associated with the use of sildenafil in a patient with sickle cell trait.

R. Nagel, A. Kassim, M. Fabry, 2000, Blood.

Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.

M. Robin, N. Russell, H. Greinix, 2013, Biology of Blood and Marrow Transplantation.

A feasibility randomized controlled trial of an mHealth app vs booklets for patient-facing guidelines in adults with SCD

M. DeBaun, R. Cronin, A. Kassim, 2023, Blood advances.

Cerebral hemodynamic changes after haploidentical hematopoietic stem cell transplant in adults with sickle cell disease

A. Kassim, S. Pruthi, Chelsea A. Lee, 2023, Blood advances.